Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2004;94:1375-1382
Published online before print April 15, 2004, doi: 10.1161/01.RES.0000128404.65887.08
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
94/10/1375    most recent
01.RES.0000128404.65887.08v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Medeiros, R.
Right arrow Articles by Calixto, J. B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Medeiros, R.
Right arrow Articles by Calixto, J. B.
Related Collections
Right arrow Cardiovascular Pharmacology
Right arrow Cell signalling/signal transduction
Right arrow Gene expression
Right arrow Receptor pharmacology
(Circulation Research. 2004;94:1375.)
© 2004 American Heart Association, Inc.


Integrative Physiology

Bradykinin B1 Receptor Expression Induced by Tissue Damage in the Rat Portal Vein

A Critical Role for Mitogen-Activated Protein Kinase and Nuclear Factor-{kappa}B Signaling Pathways

Rodrigo Medeiros, Daniela A. Cabrini, Juliano Ferreira, Elizabeth S. Fernandes, Marcelo A.S. Mori, João B. Pesquero, Michael Bader, Maria C.W. Avellar, Maria M. Campos, João B. Calixto

From the Department of Pharmacology (R.M., D.A.C., J.F., E.S.F, M.M.C., J.B.C), Universidade Federal de Santa Catarina, Brazil; Department of Pharmacology (M.C.W.A) and Department of Biophysics (M.A.S.M., J.B.P.), Universidade Federal de São Paulo, Brazil; Max Delbrück Centre for Molecular Medicine (D.A.C., M.B.), Berlin-Buch, Germany.

Correspondence to João B. Calixto, Department of Pharmacology, Centre of Biological Sciences, Universidade Federal de Santa Catarina, Rua Ferreira Lima, 82, 88015-420, Florianópolis, SC, Brazil. E-mail calixto{at}farmaco.ufsc.br or calixto3{at}terra.com.br

The bradykinin B1 receptor (B1R) is normally absent under physiological conditions, but is highly inducible during inflammatory conditions or following tissue damage. The present study attempted to determine some of the mechanisms underlying B1R upregulation following tissue injury in rat portal vein. Damage induced by tissue isolation and in vitro incubation caused a significant and time-dependent increase in des-Arg9–bradykinin (des-Arg9–BK) responsiveness that paralleled the B1R mRNA expression, as confirmed by real-time quantitative PCR. In vitro incubation of rat portal vein also induced the activation of some members of the mitogen activated protein kinase (MAPK) family, namely, extracellular signal-regulated kinase (ERK), c-Jun NH2-terminal kinase (JNK), and p38 MAPK, an effect accompanied by degradation of the inhibitory protein I{kappa}B{alpha} and translocation of nuclear transcription factor-{kappa}B (NF-{kappa}B) to the nucleus. The blockade of p38 MAPK, JNK or NF-{kappa}B, but not ERK pathways with selective inhibitors, resulted in a significant reduction of the upregulated contractile response caused by the selective B1R agonist des-Arg9–BK, and largely prevented the induction of B1R mRNA expression in the rat portal vein. Together, these results demonstrate that in vitro tissue damage induces activation of several intracellular signaling pathways that have a key role in the control of B1R expression. B1R could exert a pivotal role in the development of the cardiovascular response associated with vascular damage.


Key Words: receptor, bradykinin B1tissue damage • mitogen-activated protein kinases • portal vein • rats




This article has been cited by other articles:


Home page
StrokeHome page
M. Austinat, S. Braeuninger, J. B. Pesquero, M. Brede, M. Bader, G. Stoll, T. Renne, and C. Kleinschnitz
Blockade of Bradykinin Receptor B1 but Not Bradykinin Receptor B2 Provides Protection From Cerebral Infarction and Brain Edema * Expanded Materials and Methods
Stroke, January 1, 2009; 40(1): 285 - 293.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. A. Mori, R. C. Araujo, F. C.G. Reis, D. G. Sgai, R. G. Fonseca, C. C. Barros, V. F. Merino, M. Passadore, A. M. Barbosa, B. Ferrari, et al.
Kinin B1 Receptor Deficiency Leads to Leptin Hypersensitivity and Resistance to Obesity
Diabetes, June 1, 2008; 57(6): 1491 - 1500.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. E. Moreau, M.-T. Bawolak, G. Morissette, A. Adam, and F. Marceau
Role of Nuclear Factor-{kappa}B and Protein Kinase C Signaling in the Expression of the Kinin B1 Receptor in Human Vascular Smooth Muscle Cells
Mol. Pharmacol., March 1, 2007; 71(3): 949 - 956.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
F. G. Pelorosso, A. V. Halperin, A. M. Palma, W. Nowak, A. E. Errasti, and R. P. Rothlin
Neutral Endopeptidase Up-Regulation in Isolated Human Umbilical Artery: Involvement in Desensitization of Bradykinin-Induced Vasoconstrictor Effects
J. Pharmacol. Exp. Ther., February 1, 2007; 320(2): 713 - 720.
[Abstract] [Full Text] [PDF]


Home page
Mol. Pharmacol.Home page
M. E. Sayah, R. Medeiros, E. S. Fernandes, M. M. Campos, and J. B. Calixto
Mechanisms Underlying Lipopolysaccharide-Induced Kinin B1 Receptor Up-Regulation in the Pig Iris Sphincter in Vitro
Mol. Pharmacol., May 1, 2006; 69(5): 1701 - 1708.
[Abstract] [Full Text] [PDF]